Keymed Biosciences Inc. (HKG:2162)

Keymed Biosciences Statistics

Total Valuation

HKG:2162 has a market cap or net worth of HKD 17.38 billion. The enterprise value is 15.27 billion.

Market Cap	17.38B
Enterprise Value	15.27B

Important Dates

The next estimated earnings date is Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2162 has 294.60 million shares outstanding. The number of shares has increased by 0.70% in one year.

Current Share Class	294.60M
Shares Outstanding	294.60M
Shares Change (YoY)	+0.70%
Shares Change (QoQ)	+0.75%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	31.30%
Float	205.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.19
PB Ratio	4.96
P/TBV Ratio	4.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-54.17
EV / Sales	15.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.31

Financial Position

The company has a current ratio of 3.95, with a Debt / Equity ratio of 0.27.

Current Ratio	3.95
Quick Ratio	3.66
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	-1.02
Interest Coverage	-21.51

Financial Efficiency

Return on equity (ROE) is -8.82% and return on invested capital (ROIC) is -6.17%.

Return on Equity (ROE)	-8.82%
Return on Assets (ROA)	-5.44%
Return on Invested Capital (ROIC)	-6.17%
Return on Capital Employed (ROCE)	-9.59%
Revenue Per Employee	650,601
Profits Per Employee	-191,958
Employee Count	1,258
Asset Turnover	0.21
Inventory Turnover	0.32

Taxes

In the past 12 months, HKG:2162 has paid 3.63 million in taxes.

Income Tax	3.63M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +56.92% in the last 52 weeks. The beta is -0.05, so HKG:2162's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+56.92%
50-Day Moving Average	67.13
200-Day Moving Average	52.56
Relative Strength Index (RSI)	41.68
Average Volume (20 Days)	2,797,015

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2162 had revenue of HKD 955.73 million and -281.99 million in losses. Loss per share was -1.07.

Revenue	955.73M
Gross Profit	909.78M
Operating Income	-402.12M
Pretax Income	-278.09M
Net Income	-281.99M
EBITDA	-316.93M
EBIT	-402.12M
Loss Per Share	-1.07

Balance Sheet

The company has 3.06 billion in cash and 955.85 million in debt, giving a net cash position of 2.11 billion or 7.16 per share.

Cash & Cash Equivalents	3.06B
Total Debt	955.85M
Net Cash	2.11B
Net Cash Per Share	7.16
Equity (Book Value)	3.50B
Book Value Per Share	11.88
Working Capital	2.60B

Cash Flow

In the last 12 months, operating cash flow was -662.58 million and capital expenditures -274.01 million, giving a free cash flow of -936.59 million.

Operating Cash Flow	-662.58M
Capital Expenditures	-274.01M
Free Cash Flow	-936.59M
FCF Per Share	-3.18

Margins

Gross margin is 95.19%, with operating and profit margins of -42.07% and -29.50%.

Gross Margin	95.19%
Operating Margin	-42.07%
Pretax Margin	-29.10%
Profit Margin	-29.50%
EBITDA Margin	-33.16%
EBIT Margin	-42.07%
FCF Margin	n/a

Dividends & Yields

HKG:2162 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.70%
Shareholder Yield	-0.70%
Earnings Yield	-1.62%
FCF Yield	-5.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2162 has an Altman Z-Score of 2.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.72
Piotroski F-Score	2